Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026?

Choosing between established stability and high-tech growth often defines a portfolio. Whether you prefer the diversified reach of Abbott Laboratories (NYSE:ABT) or the specialized dominance of Intuitive Surgical (NASDAQ:ISRG), both offer compelling paths.Abbott operates a broad healthcare empire spanning baby formula to heart valves, providing steady cash flows across market cycles. Intuitive Surgical focuses intensely on robotic-assisted surgery, benefiting from an ecosystem that generates significant recurring revenue. This comparison involves weighing broad diversification against narrow, high-margin specialization in the healthcare sector.Abbott Laboratories operates across four primary segments, including medical devices, diagnostics, nutrition, and established pharmaceuticals. It sells these products globally to a diverse customer base of wholesalers, hospitals, clinics, and government agencies. In March 2026, the company completed its acquisition of Exact Sciences Corporation, a move designed to expand its presence in the cancer diagnostics market.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool